REMODULIN 2.5 mg/ml, solution for infusion bottle, 20 ml
Active ingredients: Treprostinil, Treprostinil sodium
Commercialized according to BDPMDispensing in France: Prescription only
Solution for infusionbottle, 20 mlintraveineuse;sous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- REMODULIN 2,5 mg/ml, solution pour perfusion
- Pharmaceutical form
- solution pour perfusion
- Route of administration
- intraveineuse;sous-cutanée
- Presentation description
- 1 flacon(s) en verre de 20 ml
- Marketing authorisation holder
- FERRER INTERNACIONAL (ESPAGNE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 4 Apr 2006
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60937287CIP73681621CIP133400936816213Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| TRÉPROSTINIL SODIQUEsolution | — | SA |
| TRÉPROSTINILsolution | 2,5 mg · 1 ml de solution | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.